|
TotipotentRX is a subsidiary of Cesca Therapeutics Inc. (USA “NASDAQ: KOOL”), a leading cell therapy company engaged in the research, development, and commercialization of cell-based therapeutics for use in regenerative medicine. TotipotentRX provides a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology.
We leverage Cesca’s proprietary AutoXpress ® technology platform to develop autologous stem cell-based therapies that address significant unmet needs in the immuno-oncology, vascular, cardiology and orthopedic markets.
Our products and services provide innovative technologies for:
- Processing and Delivery of Cellular Therapeutics
- Cell Manufacturing and Bio-banking
- Clinical Research and Development for Cellular Therapy
Our Operating Principles
Accountability: We accept responsibility. We take ownership of challenges and deliver on commitments.
Bias for Action: We take initiative, anticipate and address issues as they arise without waiting to be asked.
Teamwork: We share knowledge, experience and ideas openly in interactions with coworkers. We step in to help and support colleagues where necessary.
Collective Responsibility: We place organizational and/or team goals ahead of their own.We demonstrate commitment to team success in word and in deed.
One Level Up Thinking: We consider issues and opportunities as if from the vantage point of their manager when developing recommendations for a course of action.
Mutual Respect: We interact in a respectful and professional manner with colleagues at all times, challenge ideas rather than individuals.
Open Communication: We listen actively and openly share information and insight for the good of the team.
Judgement: We demonstrate maturity and wisdom in decision-making, exercise sound judgment.
Quality Policy Statement
At TotipotentRX Cell Therapy Pvt Ltd, we are committed to meet our customers’ expectations and requirements with high quality, reliable and safe products and services through open communication, effective processes, continuous improvement, and compliance with all applicable regulatory requirements.
|
